» Articles » PMID: 24967377

Differential Effects of Dry Eye Disorders on Metabolomic Profile by 1H Nuclear Magnetic Resonance Spectroscopy

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2014 Jun 27
PMID 24967377
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

We used (1)H NMR spectroscopy to analyze the metabolomic profile of reflex tears from patients with dry eye disorders (DEDs). 90 subjects were divided into 2 groups: (1) patients with DEDs (DEDG; n = 55) and (2) healthy subjects (CG; n = 35). Additionally, the DEDG was subdivided into 2 subgroups based on DED severity: mild-to-moderate and moderate (n = 22 and n = 33, resp.). Personal interviews and systematized ophthalmologic examinations were carried out. Reflex tears (20-30  μL) were collected by gently rubbing in the inferior meniscus of both eyelids with a microglass pipette and stored at -80°C until analysis. NMR spectra were acquired using a standard one-dimensional pulse sequence with water suppression. Data were processed and transferred to MATLAB for further chemometric analysis. Main differences in tear composition between DEDG and CG were found in cholesterol, N-acetylglucosamine, glutamate, creatine, amino-n-butyrate, choline, acetylcholine, arginine, phosphoethanolamine, glucose, and phenylalanine levels. This metabolic fingerprint helped also to discriminate between the three additional subgroups of DEDG. Our results suggest that tear metabolic differences between DEDG and CG identified by NMR could be useful in understanding ocular surface pathogenesis and improving biotherapy.

Citing Articles

The alterations of ocular surface metabolism and the related immunity inflammation in dry eye.

Wan X, Zhang Y, Zhang K, Mou Y, Jin X, Huang X Adv Ophthalmol Pract Res. 2025; 5(1):1-12.

PMID: 39758836 PMC: 11699629. DOI: 10.1016/j.aopr.2024.08.003.


Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease.

Lozano-Sanroma J, Barros A, Alcalde I, Alvarado-Villacorta R, Sanchez-Avila R, Queiruga-Pineiro J Diseases. 2024; 12(4).

PMID: 38667534 PMC: 11048876. DOI: 10.3390/diseases12040076.


The Plight of the Metabolite: Oxidative Stress and Tear Film Destabilisation Evident in Ocular Allergy Sufferers across Seasons in Victoria, Australia.

Aydin E, Callahan D, Chong L, Azizoglu S, Gokhale M, Suphioglu C Int J Mol Sci. 2024; 25(7).

PMID: 38612830 PMC: 11012581. DOI: 10.3390/ijms25074019.


A Review on Dry Eye Disease Treatment: Recent Progress, Diagnostics, and Future Perspectives.

Mondal H, Kim H, Mohanto N, Jee J Pharmaceutics. 2023; 15(3).

PMID: 36986851 PMC: 10051136. DOI: 10.3390/pharmaceutics15030990.


Candidate Molecular Compounds as Potential Indicators for Meibomian Gland Dysfunction.

Asiedu K Front Med (Lausanne). 2022; 9:873538.

PMID: 35685417 PMC: 9170961. DOI: 10.3389/fmed.2022.873538.


References
1.
Monleon D, Morales J, Barrasa A, Lopez J, Vazquez C, Celda B . Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2008; 22(3):342-8. DOI: 10.1002/nbm.1345. View

2.
Young S, Nessim M, Falciani F, Trevino V, Banerjee S, Scott R . Metabolomic analysis of human vitreous humor differentiates ocular inflammatory disease. Mol Vis. 2009; 15:1210-7. PMC: 2697460. View

3.
Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E . The challenge of dry eye diagnosis. Clin Ophthalmol. 2009; 2(1):31-55. PMC: 2698717. DOI: 10.2147/opth.s1496. View

4.
. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5(2):75-92. DOI: 10.1016/s1542-0124(12)70081-2. View

5.
Moss S, Klein R, Klein B . Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000; 118(9):1264-8. DOI: 10.1001/archopht.118.9.1264. View